Evidence map›Paper›PMID 41939532›Full record

ArticleInfection prevention in practice2026

Seasonality and other factors influencing hospital acquisition of multi-drug-resistant Enterobacterales colonisation: a one-year cohort study - Botswana, 2022-2023.

T D Ntereke, K Lechiile, N Mannathoko, K Mokgwathi, N Tlhako, B Moorad, T Zankere, T Gatonye, M Mokomane, M Mosepele and 9 more

Abstract read
In one paragraph

Article in Infection prevention in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

T D NterekeBotswana University of Pennsylvania Partnership, Gaborone, Botswana.
K LechiileBotswana University of Pennsylvania Partnership, Gaborone, Botswana.
N MannathokoUniversity of Botswana, Faculty of Medicine, Department of Biomedical Sciences, Gaborone, Botswana.
K MokgwathiBotswana University of Pennsylvania Partnership, Gaborone, Botswana.
N TlhakoBotswana University of Pennsylvania Partnership, Gaborone, Botswana.
B MooradBotswana University of Pennsylvania Partnership, Gaborone, Botswana.
T ZankereBotswana University of Pennsylvania Partnership, Gaborone, Botswana.
T GatonyeBotswana University of Pennsylvania Partnership, Gaborone, Botswana.
M MokomaneUniversity of Botswana, Faculty of Medicine, Department of Biomedical Sciences, Gaborone, Botswana.
M MosepeleUniversity of Botswana, Faculty of Medicine, Department of Biomedical Sciences, Gaborone, Botswana.
C CanceddaDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
M Richard-GreenblattDepartment of Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Canada.
J John-ThubukaBotswana Ministry of Health, Gaborone, Botswana.
D GoldfarbUniversity of British Columbia, Vancouver, British Columbia, Canada.
A StyczynskiDivision of Healthcare Quality & Promotion, US Centers for Disease Control & Prevention, Atlanta, USA.
G ParraDivision of Healthcare Quality & Promotion, US Centers for Disease Control & Prevention, Atlanta, USA.
R M SmithDivision of Healthcare Quality & Promotion, US Centers for Disease Control & Prevention, Atlanta, USA.
E LautenbachDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
J StryskoBotswana University of Pennsylvania Partnership, Gaborone, Botswana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Healthcare facilities may be major reservoirs for antimicrobial resistance, particularly in low- and middle-income countries, yet data are limited on factors influencing acquisition in these settings. In this cohort study, we followed up participants who screened negative for colonisation with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) on admission and assessed the incidence and risk factors for hospital acquisition of ESCrE and CRE colonisation in this population. Methods and findings: In this 12-month cohort study, we enrolled patients upon admission to a tertiary referral hospital Emergency Department in Botswana. A rectal swab was collected within 24 h of admission, and on days 3-6, 7-10, and 11-14 of hospitalisation, if still admitted. Acquisition of ESCrE and CRE was defined as a new positive swab culture in a study subject with a negative swab culture on admission. ESCrE and CRE colonisation were determined by growth on selective culture media and confirmed using automated phenotypic identification and antibiotic susceptibility testing. Associations between acquisition of ESCrE/CRE colonisation and clinical and demographic variables were analysed. Among patients with no detected colonisation at admission who remained hospitalised for ≥3 days, 81 (34.3%) and 29 (9.4%) had newly acquired ESCrE and CRE colonisation, respectively. Patients were at higher risk of ESCrE acquisition if they were hospitalised in the summer/rainy months (adjusted risk ratio, 1.49 [95% confidence interval [CI]: 1.05-2.12]). The risk of CRE acquisition was higher among patients aged <12 months (crude risk ratio, 2.58 [95% CI: 1.09-6.08]). Conclusions: High rates of hospital ESCrE and CRE acquisition in this cohort highlight the urgent need for strengthening hospital infection prevention and control programmes to mitigate transmission. Observed seasonal variation in hospital acquisition suggests that future analyses should consider seasonality as a potential confounder and investigate environmental drivers that may influence antimicrobial resistance transmission in healthcare facilities.

Indexed as

Antimicrobial-susceptibility-testingcarbapenem-resistant Enterobacterales (CRE)ColonisationEnterobacterales (ESCrE)Extended-spectrum cephalosporin-resistantHealth outcomesHospital acquisition

Identifiers

PMID41939532
PMCPMC13045617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.